- Investing Ideas
- Australian Biotech Breakthroughs
Australian Biotech Breakthroughs
Results
2
0 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
2 companies
Mesoblast
Market Cap: AU$2.8b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.24
7D
10.3%
1Y
35.8%
Aroa Biosurgery
Market Cap: AU$176.4m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.52
7D
-2.8%
1Y
27.2%